Evaluating NASDAQ:AMPH for Growth Investment Opportunities.

In this article we will dive into AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) as a possible candidate for growth investing. Investors should always do their own research, but we noticed AMPHASTAR PHARMACEUTICALS IN showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Why NASDAQ:AMPH may be interesting for canslim investors.

• In the most recent financial report, AMPHASTAR PHARMACEUTICALS IN reported a 203.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• The q2q revenue growth of 50.3% of AMPHASTAR PHARMACEUTICALS IN highlights the company's ability to generate incremental revenue and suggests positive market demand for its products or services.
• AMPHASTAR PHARMACEUTICALS IN has achieved 77.88% growth in EPS over the past 3 years, reflecting a sustained improvement in earnings performance.
• The Return on Equity (ROE) of AMPHASTAR PHARMACEUTICALS IN stands at 22.73%, reflecting the company's strong profitability and effective utilization of shareholder equity. This metric signifies the company's ability to generate returns for its investors.
• The Relative Strength (RS) of AMPHASTAR PHARMACEUTICALS IN has consistently been strong, with a current 97.24 rating. This indicates the stock's ability to exhibit relative price outperformance and reflects its competitive strength. AMPHASTAR PHARMACEUTICALS IN demonstrates promising potential for sustained price momentum.
• AMPHASTAR PHARMACEUTICALS IN exhibits a favorable Debt-to-Equity ratio at 1.07. This highlights the company's ability to limit excessive debt levels and maintain a strong equity base, demonstrating its financial stability and risk management practices.
• With institutional shareholders at 64.27%, AMPHASTAR PHARMACEUTICALS IN demonstrates a healthy ownership distribution. This reflects a mix of institutional and individual investors, creating a market environment that may foster increased trading activity and price discovery.

In-Depth Technical Analysis of NASDAQ:AMPH

Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.

We assign a technical rating of 6 out of 10 to AMPH. In the past year, AMPH was one of the better performing stocks in the market. The medium term picture became unclear, although we see some improvement happening in recent action.

• The long term trend is still neutral, but the short term trend is positive, so the stock is getting more and more appreciated by traders and investors.
• Looking at the yearly performance, AMPH did better than 97% of all other stocks. We also observe that the gains produced by AMPH over the past year are nicely spread over this period.
• AMPH is one of the better performing stocks in the Pharmaceuticals industry, it outperforms 95% of 207 stocks in the same industry.
• In the last month AMPH has a been trading in the 44.23 - 54.00 range, which is quite wide. It is currently trading near the high of this range.
• AMPH is currently trading in the middle of its 52 week range. The S&P500 Index however is trading in the upper part of its 52 week range, so AMPH is lagging the market slightly.
• Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.

For an up to date full technical analysis you can check the technical report of AMPH

A complete fundamental analysis of NASDAQ:AMPH

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

Taking everything into account, AMPH scores 7 out of 10 in our fundamental rating. AMPH was compared to 207 industry peers in the Pharmaceuticals industry. AMPH scores excellent on profitability, but there are some minor concerns on its financial health. AMPH is evaluated to be cheap and growing strongly. This does not happen too often! These ratings could make AMPH a good candidate for value and growth investing.

Check the latest full fundamental report of AMPH for a complete fundamental analysis.

More ideas for growth investing can be found on ChartMill in our CANSLIM screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.